MatthewTMenardMD
Vascular Surgery • Boston, MACo-Director, Endovascular Surgery Program Director, Vascular Surgery Fellowship
Dr. Menard is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
75 Francis St
Boston, MA 02115Phone+1 857-307-1920Fax+1 857-307-1922
Education & Training
Brigham and Women's HospitalFellowship, Vascular Surgery, 2001 - 2003
Massachusetts General HospitalResidency, Surgery, 1994 - 2001
Harvard Medical SchoolClass of 1994
Certifications & Licensure
ME State Medical License Current
MA State Medical License 1997 - 2026
RI State Medical License 2022 - 2026
CT State Medical License 2023 - 2025
AZ State Medical License 2002 - 2004- American Board of Surgery Vascular Surgery
Awards, Honors, & Recognition
- Fellow (FACS) American College of Surgeons
Clinical Trials
- Open Versus Endovascular Repair of Popliteal Artery Aneurysm Trial Start of enrollment: 2013 Feb 01
- Best Endovascular vs. Best Surgical Therapy in Patients With Critical Limb Ischemia Start of enrollment: 2014 Aug 01
Publications & Presentations
PubMed
- 8 citationsBaseline modern medical management in the BEST-CLI trial.Matthew T Menard, Michael R Jaff, Alik Farber, Kenneth Rosenfield, Michael S Conte
Journal of Vascular Surgery. 2023-09-01 - 9 citationsPerioperative complications following open or endovascular revascularization for chronic limb-threatening ischemia in the BEST-CLI Trial.Jeffrey J Siracuse, Alik Farber, Matthew T Menard, Michael S Conte, John A Kaufman
Journal of Vascular Surgery. 2023-10-01 - 244 citationsSurgery or Endovascular Therapy for Chronic Limb-Threatening Ischemia.Alik Farber, Matthew T Menard, Michael S Conte, John A Kaufman, Richard J Powell
The New England Journal of Medicine. 2022-12-22
Press Mentions
Amputations Still Avoided with Flow-Diverting Therapy for CLTI at 2 Years: PROMISE IINovember 6th, 2024- BEST-CLI Shows Lower Incidence of Major Adverse Limb Events or Death with Surgical Bypass Versus Endovascular Treatment in CLTI Patients with Adequate GSVJanuary 23rd, 2023
- Restored Blood Flow Reduces Pain and Increases QoL in Patients with PADNovember 9th, 2022
- Join now to see all
Professional Memberships
- Member
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
